Inovio Pharmaceuticals
INO
INO
213 hedge funds and large institutions have $555M invested in Inovio Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 58 increasing their positions, 60 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% less capital invested
Capital invested by funds: $682M → $555M (-$127M)
21% less call options, than puts
Call options by funds: $25.6M | Put options by funds: $32.5M
Holders
213
Holding in Top 10
–
Calls
$25.6M
Puts
$32.5M
Top Buyers
| 1 | +$14.6M | |
| 2 | +$12.2M | |
| 3 | +$4.8M | |
| 4 |
Goldman Sachs
New York
|
+$3.26M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.58M |
Top Sellers
| 1 | -$8.69M | |
| 2 | -$3.55M | |
| 3 | -$2.15M | |
| 4 |
Citigroup
New York
|
-$1.77M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$1.72M |